Literature DB >> 23219218

A simple risk score for early ischemic stroke mortality derived from National Institutes of Health Stroke Scale: a discriminant analysis.

Ali Zandieh1, Zahra Zeynali Kahaki, Homa Sadeghian, Mohammad Fakhri, Maryam Pourashraf, Sara Parviz, Majid Ghaffarpour, Mojdeh Ghabaee.   

Abstract

OBJECTIVES: The aim of the current study was to design a new simpler form of National Institutes of Health Stroke Scale (NIHSS) for use in emergency settings, and compare its predictive ability with original NIHSS score for mortality.
METHODS: A total of 152 consecutive patients with first ever ischemic stroke admitted to a university affiliated hospital were recruited. NIHSS score on admission was estimated and the predictive ability of NIHSS items for mortality at 28 days was evaluated by logistic regression. Stepwise discriminant analysis was performed on NIHSS items to obtain a discriminant function with the best discriminative ability for mortality. Further, receiver operating characteristics (ROC) curves were depicted to compare the new determined discriminant function with the original NIHSS score.
RESULTS: Cumulative rate of mortality was 11.8% for 28-day follow-up period. Among NIHSS items, scores of visual field, limb ataxia and extinction neglect were not associated with mortality (P>0.05). On the contrary, level of consciousness-commands, language and gaze were determined as independent indicators of mortality (P<0.05), and their coefficients on discriminant function were equal to 0.65, 0.44 and 0.30, respectively. In addition, area under the ROC curve of the calculated discriminant function was not statistically different from NIHSS score (P>0.05).
CONCLUSIONS: The suggested discriminant function, comprising NIHSS items of level of consciousness-commands, language and gaze, can predict 28-day mortality after ischemic stroke in a similar way to the original NIHSS score and can provide a baseline for stroke severity in emergency settings.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23219218     DOI: 10.1016/j.clineuro.2012.10.034

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  5 in total

1.  Repurposing FDA Approved Drugs as JNK3 Inhibitor for Prevention of Neuroinflammation Induced by MCAO in Rats.

Authors:  Zikra Zulfiqar; Fawad Ali Shah; Shagufta Shafique; Abdullah Alattar; Tahir Ali; Arooj Mohsin Alvi; Sajid Rashid; Shupeng Li
Journal:  J Inflamm Res       Date:  2020-12-24

2.  Comparison of Levetiracetam and sodium Valproate in migraine prophylaxis: A randomized placebo-controlled study.

Authors:  Homa Sadeghian; Rouzbeh Motiei-Langroudi
Journal:  Ann Indian Acad Neurol       Date:  2015 Jan-Mar       Impact factor: 1.383

Review 3.  Comparing the Predictive Ability of Prognostic Models in Ischemic Stroke; Derivation, Validation, and Discrimination Beyond the ROC Curve.

Authors:  Alireza Esteghamati; Nima Hafezi-Nejad; Sara Sheikhbahaei; Behnam Heidari; Ali Zandieh; Vahid Eslami
Journal:  Front Neurol       Date:  2014-01-27       Impact factor: 4.003

4.  Evidence for a Beneficial Effect of Oral N-acetylcysteine on Functional Outcomes and Inflammatory Biomarkers in Patients with Acute Ischemic Stroke.

Authors:  Maryam Sabetghadam; Mehrdokht Mazdeh; Parnaz Abolfathi; Younes Mohammadi; Maryam Mehrpooya
Journal:  Neuropsychiatr Dis Treat       Date:  2020-05-18       Impact factor: 2.570

5.  Factors related to 6-month mortality after the first-ever stroke.

Authors:  Ehsan Sarbazi; Parvin Sarbakhsh; Daryoush Savadi Oskooei; Mohammad Yazdchi; Saber Ghaffari-Fam; Seyed Morteza Shamshirgaran
Journal:  J Educ Health Promot       Date:  2018-09-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.